In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted 2021 And 2022 Projected To Be Boom Years For Electromedical Technologies, Inc. (OTCQB: EMED) As Volume Seen Reaching $17+ Million In Market For The Bioelectronics Industry Treating Chronic And Acute Pain With Its WellnessPro Plus Device And WellnessPlus POD
2021 and 2022 may be boom years for Electromedical Technologies, Inc. (OTCQB: EMED) if analyst Goldman Small Cap Research is right about the growth of the bioelectronics and neuromodulation [...]